These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4310231)

  • 41. Effect of prostaglandin F2alpha on responses on vascular smooth muscle to serotonin, angiotensin and epinephrine.
    Greenberg S; Kadowitz PJ; Diecke FP; Long JP
    Arch Int Pharmacodyn Ther; 1973 Nov; 206(1):5-18. PubMed ID: 4359826
    [No Abstract]   [Full Text] [Related]  

  • 42. The effects of catecholamines on isolated perfused coronary arteries in the dog.
    Trinker FR
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):218-25. PubMed ID: 4358296
    [No Abstract]   [Full Text] [Related]  

  • 43. Regional vascular selectivity of angiotensin II.
    Jackson EK; Herzer WA
    J Pharmacol Exp Ther; 2001 May; 297(2):736-45. PubMed ID: 11303065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vasoconstrictor-mediated increase in muscle resting thermogenesis is inhibited by membrane-stabilizing agents.
    Tong AC; Rattigan S; Dora KA; Clark MG
    Can J Physiol Pharmacol; 1997 Jul; 75(7):763-71. PubMed ID: 9315342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Excitatory and inhibitory effects of angiotensin and vasopressin on vascular smooth muscle.
    Golenhofen K; Weston AH
    J Physiol; 1975 Mar; 246(2):54P-55P. PubMed ID: 1142268
    [No Abstract]   [Full Text] [Related]  

  • 46. Enhancement of vascular smooth muscle responses to vasoactive stimuli by prostaglandin E1 and E2.
    Greenberg S; Long JP
    Arch Int Pharmacodyn Ther; 1973 Nov; 206(1):94-104. PubMed ID: 4775942
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of vasopressor agents on the vessel wall].
    Lindner E
    Med Welt; 1975 May; 26(21):1017-24. PubMed ID: 1095885
    [No Abstract]   [Full Text] [Related]  

  • 48. The relationship between the vascular responses to the peptides angiotensin and pitressin.
    Louis WJ; Doyle AE
    Clin Sci; 1966 Oct; 31(2):255-63. PubMed ID: 4289109
    [No Abstract]   [Full Text] [Related]  

  • 49. [Vascular action of angiotensin: balance between peripheral vasoconstrictive influences and vasodilating influences of central origin].
    Malméjac J; Rieu M; Roux A
    C R Seances Soc Biol Fil; 1968 Oct; 162(3):613-5. PubMed ID: 4302972
    [No Abstract]   [Full Text] [Related]  

  • 50. [Mechanisms regulating the smooth muscles of renal vessels].
    Aĭvar IuP
    Usp Fiziol Nauk; 1977; 8(4):45-61. PubMed ID: 337717
    [No Abstract]   [Full Text] [Related]  

  • 51. Influence of propranolol on the vascular effects of cadmium and isoproterenol in rabbit aorta.
    Thind GS
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):181-91. PubMed ID: 4148407
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacological effects on the mesenteric vessels studied by a new chamber technique.
    Heisig N; Siemssen S
    Bibl Anat; 1967; 9():55-60. PubMed ID: 6029905
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of endothelium and nitric oxide in the in vitro response of equine colonic venous rings to vasoconstrictor agents.
    Moore RM; Venugopalan CS; Sedrish SA; Holmes EP
    Am J Vet Res; 1997 Oct; 58(10):1145-51. PubMed ID: 9328669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of alpha-methyldopa on the vasoconstrictor responses of the rat mesenteric artery preparation to nerve stimulation.
    Malik KU; Muscholl E
    Arzneimittelforschung; 1969 Jul; 19(7):1111-3. PubMed ID: 4310200
    [No Abstract]   [Full Text] [Related]  

  • 55. Relative vasoconstrictor potencies of norepinephrine, alpha-methylnorepinephrine and octopamine.
    Kelly RJ; Burks TF
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):306-16. PubMed ID: 4153044
    [No Abstract]   [Full Text] [Related]  

  • 56. Action of angiotensin II upon renal vascular resistance.
    Hageman WE; Buckley JP
    J Pharm Sci; 1967 Jul; 56(7):876-81. PubMed ID: 4291937
    [No Abstract]   [Full Text] [Related]  

  • 57. Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed.
    Benter IF; Yousif MH; Griffiths SM; Benboubetra M; Akhtar S
    Br J Pharmacol; 2005 Jul; 145(6):829-36. PubMed ID: 15852031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Difference in sensitivity to vasoconstrictor drugs within the wall of the sheep carotid artery.
    Graham JM; Keatinge WR
    J Physiol; 1971 May; 215(1):22P-23P. PubMed ID: 5579659
    [No Abstract]   [Full Text] [Related]  

  • 59. Angiotensin-II: more than just another vasoconstrictor to treat septic shock-induced hypotension?*.
    Asfar P; Chawla L; Lerolle N; Radermacher P
    Crit Care Med; 2014 Aug; 42(8):1961-3. PubMed ID: 25029144
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacology of venular smooth muscle: new insights.
    Altura BM
    Microvasc Res; 1978 Jul; 16(1):91-117. PubMed ID: 211398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.